Supplier Type
- Trader
- contract manufacturer
- custom synthesis
- Manufacturer
- Reagent
Supplier Region
- Maharashtra(26)
- New Delhi(4)
- Gujarat(31)
- Karnataka(7)
- Andhra Pradesh(3)
- Mumbai(52)
- Hyderabad(40)
- Vadodara(7)
- Delhi(5)
- Pune(4)
- Ahmedabad(17)
- Kolkata(2)
- Bangalore(2)
- Telangana(3)
- Kerela(1)
- Tamil Nadu(3)
- Madhya Pradesh(1)
- Uttar Pradesh(2)
- Beijing(3)
- Punjab(2)
- Nagpur(1)
- Haryana(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- NOT LESS THAN 98.0%
- NLT95%
- NLT 98%
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- Min. 98%
- Min 97. 00%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- Empagliflozin intermediate, Dapagliflozin Impurity
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99.99%
- 99.98%
- 99.95%
- 99.91%
- 99.90%
- 99.9%
- 99.9
- 99.86%
- 99.85%
- 99.8%
- 99.73%
- 99.5%
- 99.42%
- 99.29%
- 99.00 %
- 99.0% MIN
- 99%+
- 99% Min
- 99% ABOVE
- 99%
- >99%
- > 99%
- 99 %
- 99
- 98+
- 98.60%
- 98.12%
- >98.0%
- 98% min
- >98%
- 98%
- 98 - 99 %
- 97-99%
- 97-99 %
- 97.57%
- 97%
- >97%
- 97 %
- 96-98%
- 96.80%
- 96.39%
- 96.14%
- 96.0% Min.
- 96% - 98%
- 96%
- 95-98%
- 95.48%
- >95%
- 95%
- 94%
- 93%
- >92%
- >90%
- 90%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 0MG TO GRAM
- 25MG
- 50mg
- 1g
- 1gm
- 5g
- 25g
- 50g
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 100mg
- 250mg
- 1000mg
- 10g
- 100g
- 250g
- 500g
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 110kg
- 121kg
- 122kg
- 125kg
- 128kg
- 153kg
- 173kg
- 250kg
- 500kg
- 1MT
- 5gms
- 50Kgs
- 200Kgs
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 35Kgs
- 95NLT %
-
3''-Acetyl-2''-hydroxy-4-(4-phenylbutoxy)benzanilide
136450-06-1
-
4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro-
162012-67-1
-
N-Acetyl-L-cysteine
616-91-1
-
2-(5-BroMo-2-Methylbenzyl)-5-(4-fluorophenyl)thiophene
1030825-20-7
-
4-(4-Phenylbutoxy)benzoic acid
30131-16-9
-
4'-Amino-N-methylacetanilide
119-63-1
-
N-(1,3-Dimethylbutyl)-N'-phenyl-p-phenylenediamine
793-24-8
-
Linagliptin
668270-12-0
-
Methyl 2-(4-(4-chlorobutanoyl)phenyl)-2-methylpropanoate
154477-54-0
-
cis-2-[(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)methyl-N,N-diethyl-1-phenylcyclopropanecarboxamide
105310-75-6
N-(3-Acetyl-2-hydroxy-phenyl)-4-(4-phenyl-butoxy)-benzamide 136450-06-1
N-(3-Chloro-4-fluoro-phenyl)-7-fluoro-6-nitro-quinazolin-4-amine 162012-67-1
N-Acetyl-L-cysteine 616-91-1
2-(5-Bromo-2-methyl-benzyl)-5-(4-fluoro-phenyl)-thiophene 1030825-20-7
N-Acetyl-N-methyl-1,4-phenylenediamine 119-63-1
N-(1,3-Dimethylbutyl)-N'-phenyl-p-phenylenediamine 793-24-8
Linagliptin 668270-12-0
Methyl 2-[4-(4-chloro-butyryl)phenyl]-2-methyl-propionate 154477-54-0
N-Acetyl-3,5-diiodo-L-tyrosine ethyl ester 21959-36-4
Phenyl Chloroformate 1885-14-9